product type,vault_rim_uuid__v,name__v,status__v,abbreviation__rim,controlled_vocabulary_type__rim,ha_code_source__rim,health_authority_code__rim,health_authority_status__rim,health_authority_version__rim,valid_as_of__rim,global_term_label__rim,cv_value_filter__rim.vault_rim_uuid__v,reference_to_new_term__v.vault_rim_uuid__v,spor_status__v,ev_code__v,spor_rms_id__v,parameter__v
Drug,7aa0df44-87b9-4309-91a5-20185cdd2415,Centralised Procedure,active__v,CP,procedure_type__rim,ema__rim,centralised,,,,,,,,AP-1,1E+11,
Device,4fccd48b-4755-498c-8e6d-d47ba3501b13,Chlorine Dioxide (ClO2) Sterilization,active__v,,sterilization_method__v,fda__rim,C101691,,,,Chlorine Dioxide (ClO2) Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Device,36398819-8d84-40c5-8fb3-5d75867c130e,Liquid Chemical Sterilization,active__v,,sterilization_method__v,fda__rim,C107418,,,,Liquid Chemical Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Device,1b1fff5a-904f-4613-94e0-518e41585967,Ethylene Oxide Sterilization,active__v,,sterilization_method__v,fda__rim,C101713,,,,Ethylene Oxide Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Drug,7c1e2edd-e3f7-43d8-8b55-94f6f2c58715,Decentralised Procedure,active__v,DCP,procedure_type__rim,ema__rim,decentralised,,,,,,,,AP-7,1E+11,
Drug,1020fb7d-6ca0-453e-8995-98b6dfd18ee5,"Gastro-resistant capsule, hard",active__v,,dosage_form__rim,edqm__rim,PDF-10212000,Current,,,,,,CURRENT,PHF00086MIG,1E+11,
Drug,87de561a-4aa7-4469-b937-a885b9c49af0,"Gastro-resistant capsule, soft",active__v,,dosage_form__rim,edqm__rim,PDF-10213000,Current,,,,,,CURRENT,PHF00088MIG,1E+11,
Drug,7da1d99c-9940-459b-9512-af05c4df9074,Gastro-resistant granules,active__v,,dosage_form__rim,edqm__rim,PDF-10206000,Current,,,,,,CURRENT,PHF00089MIG,1E+11,
Drug,7b85aba1-bbf1-47c5-a536-e5a62dda2bc9,Gastro-resistant granules for oral suspension,active__v,,dosage_form__rim,edqm__rim,PDF-50026000,Current,,,,,,CURRENT,PHF00091MIG,1E+11,
Drug,754393d5-153f-458e-8f59-2bd8c452e60b,Gastro-resistant tablet,active__v,,dosage_form__rim,edqm__rim,PDF-10225000,Current,,,,,,CURRENT,PHF748,1E+11,
Device,c511e346-8223-45db-a7ca-3ff41abb9ce2,Ozone (O3) Sterilization,active__v,,sterilization_method__v,fda__rim,C101690,,,,Ozone (O3) Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Drug,5dd676e1-2588-4e4f-80b5-b9fa10fd6a69,Temporarily unavailable,active__v,,marketing_status__v,ema__rim,,CURRENT,,,,,,,,2.3E+11,
Drug,5a6700b7-75ca-4477-83d7-a8b54d25ee90,Urgent safety measures (USM),active__v,USM,submission_subtype__rim,,,,,,,,,,,,
Drug,fa6fd29f-ad79-42fa-a7d5-63646b72b7eb,Gastroenteral emulsion,active__v,,dosage_form__rim,edqm__rim,PDF-12111000,Current,,,,,,CURRENT,PHF3191,1E+11,
Device,7469d24b-2013-4aad-ba12-e90fa28f2b8a,High Intensity Light or Pulse Light Sterilization,active__v,,sterilization_method__v,fda__rim,C101693,,,,High Intensity Light or Pulse Light Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Device,d3442a81-78e1-4483-89b4-f2fe1c9e580d,High-level Disinfectant Sterilization,active__v,,sterilization_method__v,fda__rim,C107419,,,,High-level Disinfectant Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Drug,1cd16874-08d5-46bf-bdb6-ae550dc96b3f,Gastroenteral solution,active__v,,dosage_form__rim,edqm__rim,PDF-12108000,Current,,,,,,CURRENT,PHF3188,1E+11,
Drug,e9039307-811e-4741-8194-639fc5fd64f9,Gastroenteral suspension,active__v,,dosage_form__rim,edqm__rim,PDF-12110000,Current,,,,,,CURRENT,PHF00094MIG,1E+11,
Drug,b4bff86f-dc81-48f8-aa3a-c595711a2844,Withdrawal of drug notification form,active__v,,submission_subtype__rim,hc__v,Withdrawal of drug notification form,,,,,,,,,,
Device,1ae1a3ef-2dab-40e6-ab3d-149ebc55d95e,Radiation Sterilization,active__v,,sterilization_method__v,fda__rim,C101715,,,,Radiation Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Device,8bd5cc99-87de-40fb-8975-95285bf095e4,Moist Heat or Steam Sterilization,active__v,,sterilization_method__v,fda__rim,C101714,,,,Moist Heat or Steam Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Device,72505711-5361-4438-bbb5-9a90c1de346d,Microwave Radiation Sterilization,active__v,,sterilization_method__v,fda__rim,C101694,,,,Microwave Radiation Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Drug,ee0cd14f-5d0a-4153-a9ee-75ba749da6bf,antigen unit(s),active__v,AgU,unit_of_measurement__rim,,,,,,,,,CURRENT,,1E+11,
Device,7178471f-54ca-487c-9bc4-320f43841461,Sound Waves Sterilization,active__v,,sterilization_method__v,fda__rim,C101695,,,,Sound Waves Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Drug,e8975f3e-9310-4bb5-a9e1-0e00d4e70917,Authorization to Access,active__v,,submission_subtype__rim,hc__v,Authorization to Access,,,,,,,,,,
Drug,55b88dd3-3ee5-463e-b263-2a37a2c39e84,Conversion,active__v,,submission_subtype__rim,hc__v,Conversion,,,,,,,,,,
Drug,888b2153-08d6-4c89-a83a-4f3289ee8609,Master File Closure,active__v,,submission_subtype__rim,hc__v,Master File Closure,,,,,,,,,,
Drug,56d64fd2-2bf9-44ae-831d-73f5f4ba1596,antigen unit(s)/millilitre,active__v,AgU/ml,unit_of_measurement__rim,,,,,,,,,CURRENT,,1E+11,
Drug,d3a694b5-23f3-47f3-9f1a-bd6628b95437,Update,active__v,,submission_subtype__rim,hc__v,Update,,,,,,,,,,
Drug,9a09a9b6-e543-4573-8984-5542ae051e26,Withdrawal of Authorization to Access,active__v,,submission_subtype__rim,hc__v,Withdrawal of Authorization to Access,,,,,,,,,,
Device,e6b6dc2a-cb82-4552-b322-bf162d936755,Nitrogen Dioxide Sterilization,active__v,,sterilization_method__v,fda__rim,C107416,,,,Nitrogen Dioxide Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Drug,d31a3e88-be55-4c08-a704-1d0ff9f24e51,Common,active__v,,dosage_form__rim,,,,,,,,,CURRENT,,,
Drug,5d6df2c2-8159-4c39-8a62-a6b5b9adf675,Generic application (Article 10(1) of Directive No 2001/83/EC),active__v,,legal_basis__v,xevmpd__rim,,,,,,,,,LB-2,1E+11,
Drug,c7e971d0-b2ce-424e-84c1-5326d7d9aca4,Mutual Recognition Procedure,active__v,MRP,procedure_type__rim,ema__rim,mutual-recognition,,,,,,,,AP-3,1E+11,
Device,1c18273a-f0f7-4c3a-ab71-c4e2265e14e3,Supercritical Carbon Dioxide Sterilization,active__v,,sterilization_method__v,fda__rim,C107417,,,,Supercritical Carbon Dioxide Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Drug,b323d1a3-5ec7-4910-98f8-eea5bf6ad536,Non EU authorisation procedure,active__v,Non-EU,procedure_type__rim,ema__rim,,,,,,,,CURRENT,AP-5,2E+11,
Drug,cbb11ac6-1f15-4649-bee5-f161d45fbe48,CEP and Attestations,active__v,,submission_subtype__rim,hc__v,CEP and Attestations,,,,,,,,,,
Drug,50dc0790-b7c7-4c0f-a91d-d0d68ea82d09,"CEP, Attestations and Authorization to Access",active__v,,submission_subtype__rim,hc__v,"CEP, Attestations and Authorization to Access",,,,,,,,,,
Drug,47608e3b-dd4b-41a4-beac-be2899fb5893,Conversion and Authorization to Access,active__v,,submission_subtype__rim,hc__v,Conversion and Authorization to Access,,,,,,,,,,
Drug,2f0d8ce7-4254-43b0-964f-bdcc1b68963c,"Conversion, Update and Authorization to Access",active__v,,submission_subtype__rim,hc__v,"Conversion, Update and Authorization to Access",,,,,,,,,,
Drug,72dff813-4bde-44f3-beda-4dc08fad3258,Update and Authorization to Access,active__v,,submission_subtype__rim,hc__v,Update and Authorization to Access,,,,,,,,,,
Drug,3b052d67-99db-4584-92e6-a96d9db6fbc2,"Update, CEP and Attestations",active__v,,submission_subtype__rim,hc__v,"Update, CEP and Attestations",,,,,,,,,,
Drug,2199464a-23d1-477c-8e3c-b35d08459f02,"Update, CEP, Attestations and Authorization to Access",active__v,,submission_subtype__rim,hc__v,"Update, CEP, Attestations and Authorization to Access",,,,,,,,,,
Drug,96b79a93-6c35-4f8a-b120-5409331d96ad,Update and Conversion,active__v,,submission_subtype__rim,hc__v,Update and Conversion,,,,,,,,,,
Drug,6f213470-b718-4ae2-af10-c8260102e3ca,Well-established use application (Article 13a of Directive No 2001/82/EC),active__v,,legal_basis__v,xevmpd__rim,,CURRENT,,,,,,,,1E+11,
Device,3d275a8b-65ca-4257-8269-10b003cf53c5,Peracetic Acid Sterilization,active__v,,sterilization_method__v,fda__rim,C101697,,,,Peracetic Acid Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Drug,f6296fb9-568f-4f70-94f1-2942b89735e1,Generic application (Article 13(1) of Directive No 2001/82/EC),active__v,,legal_basis__v,xevmpd__rim,,CURRENT,2,40637.52523,,,,CURRENT,,1E+11,
Drug,225e53bb-1315-4660-bfd4-a86f307f5abe,DMF Type V - Facilities and Equipment Master File (FMF),active__v,DMF Type V,submission_type__rim,hc__v,DMF Type V,,,,,,,,,,
Device,e4f964da-186e-49eb-9920-24a560203d49,Dry Heat Sterilization,active__v,,sterilization_method__v,fda__rim,C101712,,,,Dry Heat Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Device,f5c7f619-0e24-42aa-8189-df90b7b4dde7,Hydrogen Peroxide (H2O2) Sterilization,active__v,,sterilization_method__v,fda__rim,C101689,,,,Hydrogen Peroxide (H2O2) Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Drug,465dd153-ef0d-4d52-ba3e-454692a7fc61,Fixed combination application (Article 10b of Directive No 2001/83/EC),active__v,,legal_basis__v,xevmpd__rim,,,,,,,,,LB-6,1E+11,
Device,4e86e6a9-7aa2-4dd9-8f13-ba9c494ffa54,Ultraviolet Light Sterilization,active__v,,sterilization_method__v,fda__rim,C101696,,,,Ultraviolet Light Sterilization,47e1b2d4-1d82-410b-84bf-5acf683cc45f,,,,,
Drug,260222d2-e692-4de2-906d-1b49f0909078,Gastro-resistant oral suspension,active__v,,dosage_form__rim,edqm__rim,,CURRENT,,,,,,CURRENT,PHF00092MIG,2E+11,
Drug,b39fdc59-6f43-4feb-a166-6c719c9f3544,Gastro-resistant powder for oral suspension,active__v,,dosage_form__rim,edqm__rim,,CURRENT,,,,,,CURRENT,PHF00093MIG,2E+11,
Drug,3dc23ae2-589b-4684-8433-5a7ab2f82817,Analysis,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,d0340496-9f78-43d0-92e2-a97e699e185b,API Manufacture,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,0175cfc6-24be-40a7-b546-257a33041afb,API/FDF Analytical Testing,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,0df72d20-8e45-40c2-a7a8-f31e06b3a183,Clinical Bioequivalence or Bioavailability Study,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,975d275f-5bd2-493d-94e2-280640257f0f,FDF Manufacture,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,0d384d04-7450-488d-922e-a226eb103bed,Human Drug Compounding Outsourcing Facility,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,8639875a-48d4-4c85-afc8-efa00cbe0f25,In Vitro Bioequivalence or Bioanalytical Testing,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,e2a2818f-f2ce-4f6d-9bd3-6e6f3e583a0f,Label,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,6115bafd-5cc6-4da2-ad62-c39e53c9a44d,Manufacture,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,3ac9c68b-1bfa-4647-8690-3e98d9f4e6b7,Medicated Animal Feed Manufacture,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,b94ecec8-6d80-4e00-bc6e-845207061a7c,Outsourcing Animal Drug Compounding,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,a1f9bfa6-414b-4260-ab7f-92b39bf45d10,Pack,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,f0e6f7d8-20f4-4774-b160-911f2f2d1cca,Particle Size Reduction,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,b7dbf5c2-c2e3-4aba-9d4f-64a740fc13ce,Positron Emission Tomography Drug Production,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,f0667016-179f-417d-ae9e-4da7d107763d,Relabel,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,b1727fea-09f3-4f5d-95cf-61340c4c4a04,Repack,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,e6c5843f-ce3d-4453-902e-25b1c8af2e02,Salvage,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,fa8e0511-adfb-4adb-a726-17a36abdd152,SIP Foreign Seller,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,6af377f8-ac61-4ecc-82e5-ebbafdffa938,Sterilize,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,8eada960-252f-4f5c-9cf5-a2bf0838fda8,Third-Party Logistics Provider,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,2126d15e-866b-4af6-bf4e-8feb01a89081,Transfill,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
Drug,63f4c456-56b3-4eb6-a8a6-07129320bd3f,Wholesale Drug Distributor,active__v,,manufacturing_site_role__v,,,,,,,,,,,,
"Drug, Device",aa6585e1-15bb-43af-80c8-f838c5df048d,Global Application,active__v,,application_type__rim,,,,,,,,,,,,
"Drug, Device",311354ce-a101-44e4-b88b-4ce65fd968b9,Global Submission,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,5571e70a-8b16-42cb-924a-1f2d9d3eb41b,Authorised Medicinal Product,active__v,,authorisation_type__v,ema__rim,,CURRENT,1,,,,,CURRENT,,2E+11,
Drug,8426338d-eb50-4e4c-b618-fbe7b94f38dd,Investigational Medicinal Product,active__v,,authorisation_type__v,ema__rim,,CURRENT,1,,,,,CURRENT,,2E+11,
Drug,115be56f-7546-4f87-b8bf-f3ebfc84e64b,Chemical Medicinal Product,active__v,,medicinal_product_category__v,ema__rim,,CURRENT,2,,,,,CURRENT,,1E+11,
Drug,32308fe3-f5db-42ac-9634-106bb4f09eee,Immunological Medicinal Product,active__v,,medicinal_product_category__v,ema__rim,,CURRENT,2,,,,,CURRENT,,1E+11,
Drug,3d24fc47-5ce1-441c-842c-920d605b1e9f,Traditional Herbal Medicinal Product,active__v,,medicinal_product_category__v,ema__rim,,CURRENT,2,,,,,CURRENT,,1E+11,
Drug,06321b71-5472-41f8-8b39-169ab9bb08d1,Herbal Medicinal Product,active__v,,medicinal_product_category__v,ema__rim,,CURRENT,2,,,,,CURRENT,,1E+11,
Drug,49d9c216-a5b3-4b27-8fd5-781287e1a5bf,Medicinal Product derived from Human Blood or Human Plasma,active__v,,medicinal_product_category__v,ema__rim,,CURRENT,2,,,,,CURRENT,,1E+11,
Drug,0cc67bf8-0c84-4e5b-98d2-f1c3a2b29610,Advanced Therapy Medicinal Product,active__v,,medicinal_product_category__v,ema__rim,,CURRENT,2,,,,,CURRENT,,1E+11,
Drug,01ca34b4-c617-4c83-8ae6-b909541d6df5,Homeopathic Medicinal Product,active__v,,medicinal_product_category__v,ema__rim,,CURRENT,2,,,,,CURRENT,,1E+11,
Drug,61fe24e9-b43e-4cbd-b8c5-9d2c536d05fa,Radiopharmaceutical Medicinal Product,active__v,,medicinal_product_category__v,ema__rim,,CURRENT,2,,,,,CURRENT,,1E+11,
Drug,c84c2365-6ba1-4832-a2f3-d76072a7e903,Clinical Trial Application (CTA),active__v,CTA,application_type__rim,,,,,,,,,,,,
Drug,3da84a3b-345a-4b07-912d-7d46604d3a5a,Clinical Trial Notification (CTN),active__v,CTN,application_type__rim,,,,,,,,,,,,
Drug,a70fa91a-569d-44bb-9169-ab3e0e5ef11c,Investigational New Drug,active__v,IND,application_type__rim,,,,,,,,,,,,
Drug,7617057c-873e-483e-b8a8-26bc787cb85b,Global Clinical Trial,active__v,GCT,application_type__rim,,,,,,,,,,,,
Drug,4a7b7b7d-eb48-4920-970f-84b7540082a0,Clinical Trial Certificate Application,active__v,,application_type__rim,,,,,,,,,,,,
Drug,80532242-2754-42a7-ab08-f84bea65a684,Clinical Trial of Investigational Medicinal Products (CTIMP),active__v,CTIMP,application_type__rim,,,,,,,,,,,,
Drug,5949d82e-0f14-4acd-980b-2adc96a6ad66,Research Protocol Authorization,active__v,,application_type__rim,,,,,,,,,,,,
Drug,bee1b4b9-18a8-4535-9e8c-175315e60f94,EudraVigilance Veterinary Medicinal Product Dictionary,active__v,EVVetMPD,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,7664e0be-a368-4f59-ad45-91ab02111e7d,EudraVigilance Human – Active Directory,active__v,EV H – AD,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,29e734db-0a22-46e1-a5bd-0d0a5889b9a1,EudraVigilance Vet – Active Directory,active__v,EV V – AD,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,b9b70b72-09e3-48a7-9ce9-b610bc8962eb,European Inspections Database,active__v,EudraGMDP,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,828d8a83-9b77-44c1-b0c4-9b6036f6e6d6,EMA Small and Medium-sized enterprise database,active__v,EMA SME Database,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,0cecdaf1-0918-4de8-9e6a-2ffde792e254,EMA SAP Finance,active__v,EMA SAP-Finance,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,07f15989-65dd-46ce-beca-ce7e3bb887f8,GS1 Global Location Number,active__v,GS1 GLN,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,0acaa38b-230a-429d-8fa3-7447f6624e38,OMS Organisation Identifier,active__v,OMS Org_ID,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,5f19a80f-394b-4371-ba65-11cb133204af,Dun & Bradstreet’s Data Universal Numbering System,active__v,DUNS,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,da1f0478-90d6-41ef-bf95-1bc27e219ebf,OMS Location Identifier,active__v,OMS Loc_ID,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,ce610ecb-94dd-464f-826a-53d2b91e8c54,OMS Request Identifier,active__v,OMS Req_ID,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,754c02bb-f5cd-4adc-ac8b-17373d717ee3,GS1 Global Trade Item Number,active__v,GS1 GTIN,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,c5e5091c-ec48-4ef8-8711-eb5068f18853,EMA Eudra Common Directory,active__v,EMA ECD,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,bc7f87a0-0152-4ad1-83da-ea7fb6b663c7,EMA Small and Medium-sized enterprise number,active__v,EMA SME Number,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,cbb4d9ec-ad35-459d-87ce-f098414e31f8,UCUM - Unified Code for Units of Measurement,active__v,UCUM,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,f98116e5-9c9c-48ad-8938-4c9272aa5179,BfArM - Federal Institute for Drugs and Medical Devices,active__v,BfArM,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,e653d9f6-7324-4c92-93a7-975f7ef5f357,Extended EudraVigilance Medicinal Product Dictionary organisation system key,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,6fac31fc-1478-4df8-804a-8fd94f128e0c,OMS Individual Identifier,active__v,OMS Ind_ID,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,0192bddd-4669-49d0-95b0-87e187bdf264,Unique Ingredient Identifier,active__v,UNII,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,0b094dc0-cae1-4f68-8005-bd1986763147,electronic Common Technical Document,active__v,eCTD,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,4a16283b-e601-48bb-b6b9-977cc0545720,European Databank on Medical Devices,active__v,EUDAMED,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,23721b0c-b29b-412b-a38f-119824fa3668,European Inspections Database organisation system key,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,2aed3d73-4bb2-48b8-9492-54ca65af44be,EU Interinstitutional Style Guide,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,48d86c65-41fd-47e3-9e53-b25b99c995e5,Product Management Services,active__v,PMS,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,b2489990-af24-412f-858c-0612dee9e0ab,Applicant’s document,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,524315e5-c454-4bb4-b466-48074ca6121f,Applicant’s document,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,ce4084a8-e487-4af6-885d-b506798b7e3d,Substance Validation Group,active__v,SVG,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,506c62e5-c1a3-4341-9bb2-02210f98b3b1,3-letter ISO 639-3 Codes for the representation of names of languages,active__v,ISO 639-3 alpha-3,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,c8fa1ad1-d92c-421f-963b-1afaa19a95e1,EudraVigilance Human Dynamics,active__v,EV_HD,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,ff283a34-1261-4d7b-8956-1109b27193dc,Medical Dictionary for Regulatory Activities,active__v,MedDRA,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,dcaae248-af96-47f8-84ff-5fbd6c26f914,Veterinary Dictionary For Drug Regulatory Activities,active__v,VedDRA,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,e88aec14-70fb-40e4-b982-4e3fd8d11c28,Representation of human sexes,active__v,ISO 5218,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,ba126917-1fcf-4ac1-9f94-f13da127f885,European Union Telematics Controlled Terms,active__v,EUTCT,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,3fe86de6-0c18-4e6b-b545-f86ff147a253,EudraVigilance Veterinary Dynamics,active__v,EV_VD,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,3b07ac64-744e-4b7c-9f26-45645bcff376,PROTEIN DATA BANK (PDB),active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,19e7cae3-b09e-41b0-9646-a6e8ef1a40de,EUROPEAN FOOD SAFETY AUTHORITY (EFSA),active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,56806b1e-7b67-45dc-9502-60ddbc56b4f5,INDEX FUNGORUM,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,a42d52d5-b707-4991-8ad7-88ad4ab84e97,CHINA FOOD AND DRUG ADMINISTRATION,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,151ab56d-52ac-4738-8f90-902d22591d5c,Veterinary International Conference on Harmonization,active__v,VICH,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,444b175e-4ca3-4a81-91f7-78aa281aae19,FOOD AND DRUG ADMINISTRATION,active__v,FDA,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,3e685251-c6d1-4b3f-aa50-31d4662da76b,2-letter ISO 3166-1 Codes for the representation of names of countries and their subdivisions,active__v,ISO 3166-1 alpha-2,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,c28a6a83-29c2-43c4-9ee4-b11ac94fe48e,3-letter ISO 3166-1 Codes for the representation of names of countries and their subdivisions,active__v,ISO 3166-1 alpha-3,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,7cc7364f-dd41-464a-a094-04315c7c9d7e,World Health Organization-Adverse Reaction Terminology,active__v,WHO-ART,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,ad5c49e4-cfb2-4fec-8455-1be7f2e67b42,Hoechst Adverse Reaction Terminology,active__v,HARTS,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,c261e2e3-f7c6-4a24-a66c-72f24db6f69f,Coding Symbols for a Thesaurus of Adverse Reaction Terms.,active__v,COSTART,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,95722a04-88df-403e-a6f7-ad78313aef86,International Statistical Classification of Diseases and Related Health Problems,active__v,ICD,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,8c1d5986-8285-4a04-9995-bb27f5dbb2b7,Japanese Adverse Reaction Terminology,active__v,J-ART,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,5530d7e7-2592-4258-973a-1fbdf8f163bc,ISO 639-1 Codes for the representation of names of languages,active__v,ISO 639-1,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,0f84ce14-24eb-4d69-b7af-fec57319b21e,"Standard Terms for dosage forms, routes of administration and containers",active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,4764a2f9-fb78-4176-ad8d-0fbd2bb289ba,Anatomical Therapeutic Chemical Classification System - Human,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,7477a4c7-6a7b-46ba-bf29-32f818b3940c,Extended EudraVigilance Medicinal Product Dictionary,active__v,xEVMPD,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,a1d6e9fb-3baf-414c-bc6a-9bb3bf671f8e,INN,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,46ac88f8-26d2-499a-9543-6e98c2bb6ca9,Maximum Residue Limit Species,active__v,MRL Species,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,d0c0a65f-c4ff-40d8-a2b1-ed6a3df80808,Target Species,active__v,Target Species,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,16b56af0-b463-42e0-803c-54a60dec9b8d,4-letter ISO 3166-3 Codes for the representation of names of countries and their subdivisions,active__v,ISO 3166-3 alpha-4,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,ec8bb97d-b079-4ead-9f1b-8daa4900c990,Drug Information System of the National Competent Authorities in Germany,active__v,AMIS,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,f5d2d550-558f-4aad-8362-086d800beef4,Anatomical Therapeutic Chemical classification system - Veterinary,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,e0537a1b-915f-4fe4-b9ab-e1f37b7ce40d,Annex I of the Commission Regulation (EC) No 1234/2008 of 24 November 2008 - Variations Regulation,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,5e9d9996-0dbe-4ed3-b5ad-d8e6ebba5bbf,"Annex of the Guideline on the details of the various categories of variation, as published on the 12th December 2008",active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,ddca986d-c45d-4107-8f8d-7754a1536626,"Annex of the Guideline on the details of the various categories of variation, as published on the 16th May 2013",active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,a5e57898-56ad-432e-897c-16efc63edd4b,Application Form for a variation to a Marketing Authorisation,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,12434690-f46c-4d74-a1ca-932350b913b6,SIAMED - EMA CP management system,active__v,,id_source__v,ema__rim,,CURRENT,,,,,,CURRENT,,1E+11,
Drug,d93d31d5-91b8-467c-ac0c-76f71bcb7c86,Public,active__v,,confidentiality_indicator__rim,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,75ad836b-4996-4c07-9b7f-517a50d6f44e,Confidential,active__v,,confidentiality_indicator__rim,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,3ab4058d-d986-4968-acd2-b0be9521f997,Restricted,active__v,,confidentiality_indicator__rim,ema__rim,,CURRENT,,,,,,CURRENT,,2E+11,
Drug,b5958daa-e799-4df0-a71d-8469c5879392,Yes,active__v,,paediatric_use__v,,,,,,,,,,,,
Drug,583a5996-876b-4598-8cc3-39a597e5eb57,No,active__v,,paediatric_use__v,,,,,,,,,,,,
Drug,3026d210-1df0-4425-9fed-1a4c944e2302,Administrative Change,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,fc7eb492-4053-4495-b08d-ecd609e80138,Adverse Event Report,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,bcbe56cb-10b3-4fc8-9015-8ae14510240a,Annual Safety Report (ASR) / Development Safety Update Report (DSUR),active__v,ASR/DSUR,submission_type__rim,,,,,,,,,,,,
Drug,b4259110-509c-4a92-975f-1d58681ce61d,Bioequivalence Studies,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,8176836a-8bd9-4c0a-8a2a-ee47b895736f,Clinical Trial Report,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,e86f4f93-eb79-49da-99d0-577e8b97673b,CTIMP Authorization,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,6734470f-6591-4465-8dbe-f3a5b616877a,Dossiê Específico de Ensaio Clínicos (DEEC),active__v,DEEC,submission_type__rim,,,,,,,,,,,,
Drug,54fa33de-89ea-40aa-91b9-b7614361b9b6,Dossier de Desenvolvimento Clínico de Medicamento (DDCM),active__v,DDCM,submission_type__rim,,,,,,,,,,,,
Drug,b14fc094-6752-4a2f-8754-afca0fbe0f5e,Early Phase Trial Application,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,a7b5bc81-25bc-42b7-9db6-9c0356cf9c32,Final Clinical Study Report,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,a4a21b18-4556-4f10-a19b-e69d94c261bd,Final Report,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,65fbf61a-770e-4144-8b50-97bf96f836cb,Phase IV Trial Application,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,21887e74-4516-4993-a320-ef3a05102ec5,Radiation Dose Exceeded Report,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,e12140cf-78e4-4134-9d65-1dd1e41af8d7,Report,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,9974ca92-fcbe-44a9-9f81-70729c8e7b89,Response,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,2f7edcf8-8cd0-4228-b3d9-3104e7d7def3,Safety and Protective Measures Notification,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,b38f2d6f-bae3-4540-86b9-016361a67a49,Safety update,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,849f40ed-7861-4735-8b67-be40e9ad5b3b,Serious Breach,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,3bc5745b-8709-4626-8cc9-5b0f83f8c59a,Six-Month Progress Report,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,3accfaa5-09aa-4f5f-b243-83c78b61748e,Suspected Unexpected Serious Adverse Reaction (SUSAR),active__v,SUSAR,submission_type__rim,,,,,,,,,,,,
Drug,b72051f9-d844-4901-99ca-c4897789754f,Suspension of Trial,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,f76f362e-212b-47b0-85b3-3167fb8d4d5e,Temporary Authorization,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,cc1ed275-78cb-422e-b5ec-67d71eac60d2,Trial Completion,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,53e35249-d896-4a5d-80c5-44845972c3cc,Trial Status Report,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,0c7869f6-7711-43ee-b7e7-2a0975a23494,Trial Suspension,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,8fb9d9bc-63aa-40bf-ac5a-52a432a84f2a,Trial Termination,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,3b2803ed-f8aa-4c05-89a6-6c8d11230b3d,Update to Investigator’s Brochure or New Safety Information,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,c5d2566d-e3ca-400d-b409-93ea7d7a6170,Updated GMP Certification,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,05744d39-15a8-4eb6-86f1-5a8a87dbb614,Urgent Safety Measures,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,fe4a25aa-58d8-4410-8d8d-80e7b7149b23,Yearly progress report,active__v,,submission_type__rim,,,,,,,,,,,,
Drug,b69fbab5-f6bb-4f2f-87ae-643c4b2b786a,MedTech Validation,active__v,,dtd_xsd_version__v,,,,,,,da650891-63aa-4bb0-8d8e-b2c571fabda0,,,,,
Drug,34dbc9ee-0ce1-4a44-bec5-5adca7c6f785,Addition of Site,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,4ecc00ee-b22a-477c-8120-9bc3b68be92d,Administrative Change,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,3350a15f-1ceb-4bd7-88cd-7801f8977934,Adverse Event Report,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,6bf671d2-e96d-4de2-a5b2-7604a0d4ce95,Amendment,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,88832564-7419-49e9-ad1e-9c2f98595859,Annual Progress Report,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,e6a1efa6-7a53-44b9-86ed-501206ac8391,Annual Report,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,cc1c3c30-18a1-40d4-a5a2-1da2bc518133,Bioequivalence Response,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,79361bb7-3637-43b3-8de4-31f1da7a4f79,Biological Products,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,b29c5a34-4b66-45fd-bed7-2d24fdb5963e,Clinical Study Report,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,7bbe402c-4e3e-480a-b6be-62924a31e9a2,Completion,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,a5e82ad5-fa4b-47ae-805b-8b86a7316e83,CTC Response,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,82b8b7f0-0c63-4f24-8276-76c1c9db1c21,Development Safety Update Report (DSUR),active__v,DSUR,submission_subtype__rim,,,,,,,,,,,,
Drug,6d0c5197-5e6f-4f53-860c-3705a47e2b66,Final Report,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,17e8e90e-f949-48a8-a5a4-8c25254fdf48,Herbal Products,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,0399f67a-9270-4f2d-93cd-586093d1dab8,Interim Analysis Report (IAR),active__v,IAR,submission_subtype__rim,,,,,,,,,,,,
Drug,33e3f4ef-3604-4241-9cd5-a9768840c019,Interim Report,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,d305f955-e517-4b2e-ad6a-906cf683684f,Modification,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,8a325ef6-5fb7-44ee-8112-394c89ea6cea,New Investigator Requirements,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,b2423910-a510-4a47-b49e-6ef8d4ba32f1,Non-substantial Amendment,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,6e9ccb6e-e095-496f-96e1-56a71296ed83,Periodic Safety Update Report (PSUR),active__v,PSUR,submission_subtype__rim,,,,,,,,,,,,
Drug,8babe7c9-28aa-4c59-bfb5-d73dcc6358fd,Radiopharmaceutical Products,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,a798e4d7-a56b-4454-b006-eef7c6d0f1d3,Reactivation,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,89a22f90-eae5-46d2-8235-be06dabc3b52,Report,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,2d0f3234-e150-4ba1-a3d7-1297cb9f7bc3,Serious Adverse Event,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,8166bbe6-c9eb-4995-b5c3-8be0719c1ff6,Site Addition,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,f0e62a59-c04d-444c-99b6-7fcf26cab163,Site Closure,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,56fcd160-d73a-49b1-b951-a40356cc9f5c,Site Closure or Deletion,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,294e2a63-3403-48cb-8019-a9fc12c1467c,Six-Month Progress Report,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,bd2631dd-84c4-4a6f-a23b-075f9c1f6edb,Substantial Amendment,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,abe50b7e-025c-4824-8a7b-e288f7030b47,Suspected Unexpected Serious Adverse Reactions (SUSAR),active__v,SUSAR,submission_subtype__rim,,,,,,,,,,,,
Drug,7ed5320c-8061-4a31-8d3b-3ddea9c551ae,Synthetic Drugs,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,e2d08e8f-3e8b-4706-bee1-284ec6cd3f94,Termination,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,af91347a-67c1-420a-9af1-3c9cdb8d3c07,Update Report of the Experimental Drug Development,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,c3258a29-92e0-4d24-988d-432838142b73,Variation,active__v,,submission_subtype__rim,,,,,,,,,,,,
Drug,7b178f59-470e-4b76-b2cb-f06e895e6d97,Clinical Trial Regulation (CTR),active__v,,procedure_type__rim,,,,,,,,,,,,
Device,9b06f4ba-8216-4a3d-bf7b-ed821741403f,CE Mark Procedure,active__v,,procedure_type__rim,,,,,,,,,,,,
Drug,014ef51c-e143-42f4-bdd8-01c2a50adab7,US 4.3 (CDER),active__v,,dtd_xsd_version__v,fda__rim,,,,,,da650891-63aa-4bb0-8d8e-b2c571fabda0,,,,,
Drug,64ad5e3d-dd63-40b2-b643-eba2bbbad480,US 4.3 (CBER),active__v,,dtd_xsd_version__v,fda__rim,,,,,,da650891-63aa-4bb0-8d8e-b2c571fabda0,,,,,
Drug,85d1eed4-a256-49d0-854f-e0aa15e47947,Yes,active__v,,paediatric_use__v,,,,,,,,,,,,
Drug,b3f970c1-01c3-4f69-8b50-561eba335f5f,No,active__v,,paediatric_use__v,,,,,,,,,,,,